Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$20,966,880
+$16,532,880 QoQ
Shares Held
363,882
+397.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#271
of 2,506 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. BMY ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
|
50,310 | $18,218,257 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,966,880 | 363,882 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,434,000 | 73,108 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,583,618 | 47,898 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,771,002 | 194,479 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $402,769 | 8,701 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $305,742 | 5,013 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $394,788 | 6,980 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $219,739 | 4,247 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $161,593 | 3,891 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $53,198 | 981 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $44,229 | 862 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $52,584 | 906 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $65,484 | 1,024 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $106,668 | 1,539 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $111,738 | 1,553 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $109,762 | 1,544 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $170,170 | 2,210 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $157,014 | 2,150 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $295,539 | 4,740 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $289,696 | 4,896 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $311,782 | 4,666 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $234,845 | 3,786 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $211,678 | 3,511 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $361,561 | 6,149 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $321,787 | 5,773 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||